Microba Life Sciences, a precision microbiome science company, and Ginkgo Bioworks , the leading horizontal platfor...
The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing a...
Australia-based Microba Life Sciences commences trading on the Australian Securities Exchange following the completion o...
French firm Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Japan's Teij...
SeaX Ventures (Southeast Asia Exponential Ventures), with operations in the US & Thailand, has announced the close o...
Telix Pharmaceuticals has announced that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) P...
US' Halozyme Therapeutics has announced a global collaboration and license agreement with Japan's Chugai Pharmaceutical ...
China's Zhimeng Biopharma, Inc., an innovation-driven biopharmaceutical company focused on the development of innovative...
China's JW Therapeutics has received the Investigational New Drug (IND) clearance from the National Medical Products Adm...
China's CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercial...
China's Biosion, Inc., and US' Pyxis Oncology have entered into an agreement under which Pyxis Oncology will be granted ...
Gilead Sciences announced data from multiple studies highlighting the clinical benefit and differentiation of its hepati...
Takeda has received approval from the Ministry of Health, Labour and Welfare (MHLW) for TAKHZYRO (lanadelumab) subc...
Australia's Telix Pharmaceuticals announced that the United States Food and Drug Administration (FDA) has granted Orphan...
Biocytogen Pharmaceuticals (Beijing) Co., has announced the opening of the Biocytogen Europe Innovation Centre (BEIC) in...
InnoCare Pharma has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical P...
Innovent Biologics and Eli Lilly and Company have announced that the companies will now expand the strategic partnership...
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...
Australia's Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company developing next-generation products to...
CARsgen Therapeutics, a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies...
Prestige BioPharma, a Singapore-based biopharmaceutical with operations in USA and South Korea, announced positive effic...
VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of i...
Telix Pharmaceuticals announces it has made significant progress in advancing the Company's glioblastoma multiforme (GBM...
OBiO Technology has completed its initial public offering ("IPO") process and started trading on the Shanghai Stock...
Oncoshot has announced it will be welcoming Dr Bernard Ng, Chief Scientific Officer of Milltrust Ventures, to its adviso...
